Drug Policy Program
E27449
The Drug Policy Program is a research and policy initiative at Rice University's Baker Institute that analyzes and advocates for evidence-based approaches to drug laws and regulation.
All labels observed (1)
| Label | Occurrences |
|---|---|
| Drug Policy Program canonical | 1 |
How this entity was disambiguated
This entity first appeared as the object of triple T215848 — resolving that mention is where its identity was fixed. The disambiguator weighed these candidate entities and picked the highlighted one (or “None”, minting a new entity). This is how homonymy is resolved: the same surface form can point to different entities.
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: Drug Policy Program Context triple: [Rice University Baker Institute for Public Policy, hasProgram, Drug Policy Program]
-
A.
National Institute on Drug Abuse
The National Institute on Drug Abuse is a U.S. federal research agency that leads scientific study on drug use, addiction, and their health impacts to inform prevention, treatment, and policy.
-
B.
Office of National Drug Control Policy
The Office of National Drug Control Policy is a U.S. federal agency that coordinates and oversees national drug-control strategy and policies across the government.
-
C.
Drug-Free Communities Support Program
The Drug-Free Communities Support Program is a federal grant initiative that funds and supports local community coalitions in their efforts to prevent youth substance use across the United States.
-
D.
Substance Abuse and Mental Health Services Administration
The Substance Abuse and Mental Health Services Administration (SAMHSA) is a U.S. federal agency within the Department of Health and Human Services that leads national efforts to improve behavioral health and reduce the impact of substance abuse and mental illness.
-
E.
Global Drug Facility
The Global Drug Facility is an international initiative that improves worldwide access to quality-assured tuberculosis medicines and diagnostics, particularly in low- and middle-income countries.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: Drug Policy Program Target entity description: The Drug Policy Program is a research and policy initiative at Rice University's Baker Institute that analyzes and advocates for evidence-based approaches to drug laws and regulation.
-
A.
National Institute on Drug Abuse
The National Institute on Drug Abuse is a U.S. federal research agency that leads scientific study on drug use, addiction, and their health impacts to inform prevention, treatment, and policy.
-
B.
Office of National Drug Control Policy
The Office of National Drug Control Policy is a U.S. federal agency that coordinates and oversees national drug-control strategy and policies across the government.
-
C.
Drug-Free Communities Support Program
The Drug-Free Communities Support Program is a federal grant initiative that funds and supports local community coalitions in their efforts to prevent youth substance use across the United States.
-
D.
Substance Abuse and Mental Health Services Administration
The Substance Abuse and Mental Health Services Administration (SAMHSA) is a U.S. federal agency within the Department of Health and Human Services that leads national efforts to improve behavioral health and reduce the impact of substance abuse and mental illness.
-
E.
Global Drug Facility
The Global Drug Facility is an international initiative that improves worldwide access to quality-assured tuberculosis medicines and diagnostics, particularly in low- and middle-income countries.
- F. None of above. chosen
Statements (41)
| Predicate | Object |
|---|---|
| instanceOf |
policy program
ⓘ
research program ⓘ |
| affiliatedWith | Rice University ⓘ |
| aimsTo |
advocate for evidence-based drug policy
ⓘ
analyze drug laws ⓘ analyze drug regulation ⓘ inform policymakers ⓘ inform the public ⓘ |
| country |
United States of America
ⓘ
surface form:
United States
|
| engagesIn |
academic research
ⓘ
advocacy for drug policy reform ⓘ policy analysis ⓘ public outreach ⓘ stakeholder engagement ⓘ |
| field |
criminal justice policy
ⓘ
drug law reform ⓘ public health ⓘ public policy ⓘ |
| focusesOn |
drug laws
ⓘ
drug policy ⓘ drug regulation ⓘ evidence-based policy ⓘ |
| hostInstitution |
Rice University Baker Institute for Public Policy
ⓘ
surface form:
Baker Institute for Public Policy
|
| locatedIn |
Houston
ⓘ
surface form:
Houston, Texas
|
| partOf |
Rice University Baker Institute for Public Policy
ⓘ
surface form:
James A. Baker III Institute for Public Policy
|
| produces |
briefing papers
ⓘ
legislative testimony ⓘ policy reports ⓘ research publications ⓘ |
| serves |
advocates
ⓘ
general public ⓘ policymakers ⓘ researchers ⓘ |
| topic |
criminal justice reform
ⓘ
harm reduction ⓘ marijuana policy ⓘ opioid policy ⓘ public health approaches to drug use ⓘ |
| university | Rice University ⓘ |
| usesApproach |
evidence-based analysis
ⓘ
interdisciplinary research ⓘ |
How these facts were elicited
The pipeline generated the facts above by prompting gpt-5.1 with this entity's name + description and the instruction below.
Instruction
You are a knowledge base construction expert. Given a subject entity and a description of it, return factual statements that you know for the subject as a JSON list of dictionaries(triples), where keys must be "subject", "predicate" and "object". The number of facts may be very high, between 25 to 50 or more, for very popular subjects. For less popular subjects, the number of facts can be very low, like 5 or 10. # Requirements - If you don't know the subject at all, return an empty list. - If the subject is not a named entity, return an empty list. - Include at least one triple where predicate is "instanceOf". - Do not get too wordy. - Separate several objects into multiple triples with one object.
Input
Subject: Drug Policy Program Description of subject: The Drug Policy Program is a research and policy initiative at Rice University's Baker Institute that analyzes and advocates for evidence-based approaches to drug laws and regulation.
Referenced by (1)
Full triples — surface form annotated when it differs from this entity's canonical label.